Intramedullary Nails Market By Product Type, By Material, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

List of Tables

The global intramedullary nail market is anticipated to reach $1,032.0 million by 2032, growing from $1,708.9 million in 2022 at a CAGR of 5.6% from 2023 to 2032.

The intramedullary nail market refers to the industry involved in the manufacturing, distribution, and sale of intramedullary nails, which are medical gadgets used in orthopedic surgeries to stabilize fractures of lengthy bones, specifically in the femur, tibia, and humerus. Intramedullary nails are commonly made of materials like stainless steel or titanium and are inserted into the medullary canal of the bone to supply structural support during the recovery process. They are used in approaches such as fracture fixation, correction of deformities, and joint fusion. The industry encompasses a range of types of intramedullary nails, which include those designed for precise bones, unique patient populations, and specialized surgical techniques.

The growing popularity of sports and recreational activities has led to a higher incidence of sports-related injuries, including fractures. Athletes often require surgical intervention, including the use of intramedullary nails, to facilitate faster recovery and return to activity. Improvements in healthcare infrastructure, particularly in emerging markets, increase access to orthopedic care and surgical procedures. This expansion contributes to the growth of the intramedullary nail market by broadening the patient population receiving treatment. Favorable reimbursement policies and insurance coverage for orthopedic surgeries encourage patients to seek necessary treatment, including the use of intramedullary nails, without significant financial burden. Factors such as developments in technology, increasing incidence of fractures due to growing elderly populations and sports injuries, and rising demand for minimally invasive surgical strategies make a contribution to the growth and dynamics of the intramedullary nail market.

Inadequate reimbursement rates or restrictions on coverage for intramedullary nail procedures may create financial barriers for patients and healthcare providers. Limited reimbursement can reduce procedure volumes and hinder market expansion, particularly in regions with constrained healthcare budgets. Socioeconomic disparities, including disparities in access to healthcare, education, and resources, can influence the demand for orthopedic treatments such as intramedullary nails. Lower-income populations may face challenges in accessing advanced orthopedic care, affecting market growth in certain demographics.

The increasing incidence of traumatic injuries resulting from accidents, sports-related incidents, and natural disasters highlights the importance of effective trauma management strategies. Intramedullary nails are crucial in the stabilization and reconstruction of fractured long bones, providing opportunities for market growth in the trauma sector. Manufacturers can develop specialized trauma implants, instrumentation, and surgical techniques to address the evolving needs of trauma surgeons and emergency care providers. The growing preference for minimally invasive surgical approaches creates opportunities for intramedullary nail manufacturers to develop and market implants specifically designed for less invasive procedures. Smaller incisions, reduced tissue trauma, and faster recovery times associated with minimally invasive techniques appeal to both patients and surgeons, driving adoption of such techniques and market expansion.

The key players profiled in this report include Stryker, B. Braun Melsungen AG, Zimmer Biomet, Smith+Nephew, Johnson & Johnson, Orthopaedic Implant Company, Orthofix Holdings, Inc., Wright Medical Group N.V., Advanced Orthopaedic Solutions, and Aysam Ortopedi & Tibbi Cihazlar. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intramedullary nails market analysis from 2022 to 2032 to identify the prevailing intramedullary nails market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intramedullary nails market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intramedullary nails market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Analysis of raw material in a product (by %)
End user preferences and pain points
Investment Opportunities
Upcoming/New Entrant by Regions
Technology Trend Analysis
Distributor margin Analysis
Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Regulatory Guidelines
Additional company profiles with specific to client's interest
Brands Share Analysis
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Per Capita Consumption Trends
SWOT Analysis
Volume Market Size and Forecast

Key Market Segments

By Application

Femoral Intramedullary nail
Tibial Intramedullary Nail
Gamma Intramedullary Nail
Others

By End User

Hospitals
Specialty clinics
Others

By Product Type

Upper Bone Extremities
Lower Bone Extremities

By Material

Stainless Steel
Titanium

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of LAMEA

Key Market Players:

Stryker
B. Braun Melsungen AG
Zimmer Biomet
Smith+Nephew
Johnson & Johnson
Orthopaedic Implant Company
Orthofix Holdings, Inc.
Wright Medical Group N.V.
Advanced Orthopaedic Solutions
Aysam Ortopedi & Tibbi Cihazlar

Product Code: A11434

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
3.5. Average Selling Price
3.6. Market Share Analysis
3.7. Brand Share Analysis
3.8. Trade Data Analysis
3.9. Product Consumption
3.10. Value Chain Analysis
3.11. Key Regulation Analysis
3.12. Patent Landscape
3.13. Regulatory Guidelines
3.14. Key Players Details
3.15. Reimbursement Scenario

CHAPTER 4: INTRAMEDULLARY NAILS MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Upper Bone Extremities
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Lower Bone Extremities
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: INTRAMEDULLARY NAILS MARKET, BY MATERIAL

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Stainless Steel
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Titanium
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: INTRAMEDULLARY NAILS MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Femoral Intramedullary nail
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Tibial Intramedullary Nail
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Gamma Intramedullary Nail
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Others
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country

CHAPTER 7: INTRAMEDULLARY NAILS MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Hospitals
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Specialty clinics
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: INTRAMEDULLARY NAILS MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Product Type
- 8.2.3. Market size and forecast, by Material
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by Product Type
  - 8.2.6.1.2. Market size and forecast, by Material
  - 8.2.6.1.3. Market size and forecast, by Application
  - 8.2.6.1.4. Market size and forecast, by End User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by Product Type
  - 8.2.6.2.2. Market size and forecast, by Material
  - 8.2.6.2.3. Market size and forecast, by Application
  - 8.2.6.2.4. Market size and forecast, by End User
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by Product Type
  - 8.2.6.3.2. Market size and forecast, by Material
  - 8.2.6.3.3. Market size and forecast, by Application
  - 8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Product Type
- 8.3.3. Market size and forecast, by Material
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by Product Type
  - 8.3.6.1.2. Market size and forecast, by Material
  - 8.3.6.1.3. Market size and forecast, by Application
  - 8.3.6.1.4. Market size and forecast, by End User
  - 8.3.6.2. UK
  - 8.3.6.2.1. Market size and forecast, by Product Type
  - 8.3.6.2.2. Market size and forecast, by Material
  - 8.3.6.2.3. Market size and forecast, by Application
  - 8.3.6.2.4. Market size and forecast, by End User
  - 8.3.6.3. France
  - 8.3.6.3.1. Market size and forecast, by Product Type
  - 8.3.6.3.2. Market size and forecast, by Material
  - 8.3.6.3.3. Market size and forecast, by Application
  - 8.3.6.3.4. Market size and forecast, by End User
  - 8.3.6.4. Spain
  - 8.3.6.4.1. Market size and forecast, by Product Type
  - 8.3.6.4.2. Market size and forecast, by Material
  - 8.3.6.4.3. Market size and forecast, by Application
  - 8.3.6.4.4. Market size and forecast, by End User
  - 8.3.6.5. Italy
  - 8.3.6.5.1. Market size and forecast, by Product Type
  - 8.3.6.5.2. Market size and forecast, by Material
  - 8.3.6.5.3. Market size and forecast, by Application
  - 8.3.6.5.4. Market size and forecast, by End User
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by Product Type
  - 8.3.6.6.2. Market size and forecast, by Material
  - 8.3.6.6.3. Market size and forecast, by Application
  - 8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Product Type
- 8.4.3. Market size and forecast, by Material
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. China
  - 8.4.6.1.1. Market size and forecast, by Product Type
  - 8.4.6.1.2. Market size and forecast, by Material
  - 8.4.6.1.3. Market size and forecast, by Application
  - 8.4.6.1.4. Market size and forecast, by End User
  - 8.4.6.2. Japan
  - 8.4.6.2.1. Market size and forecast, by Product Type
  - 8.4.6.2.2. Market size and forecast, by Material
  - 8.4.6.2.3. Market size and forecast, by Application
  - 8.4.6.2.4. Market size and forecast, by End User
  - 8.4.6.3. India
  - 8.4.6.3.1. Market size and forecast, by Product Type
  - 8.4.6.3.2. Market size and forecast, by Material
  - 8.4.6.3.3. Market size and forecast, by Application
  - 8.4.6.3.4. Market size and forecast, by End User
  - 8.4.6.4. South Korea
  - 8.4.6.4.1. Market size and forecast, by Product Type
  - 8.4.6.4.2. Market size and forecast, by Material
  - 8.4.6.4.3. Market size and forecast, by Application
  - 8.4.6.4.4. Market size and forecast, by End User
  - 8.4.6.5. Australia
  - 8.4.6.5.1. Market size and forecast, by Product Type
  - 8.4.6.5.2. Market size and forecast, by Material
  - 8.4.6.5.3. Market size and forecast, by Application
  - 8.4.6.5.4. Market size and forecast, by End User
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by Product Type
  - 8.4.6.6.2. Market size and forecast, by Material
  - 8.4.6.6.3. Market size and forecast, by Application
  - 8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Product Type
- 8.5.3. Market size and forecast, by Material
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by Product Type
  - 8.5.6.1.2. Market size and forecast, by Material
  - 8.5.6.1.3. Market size and forecast, by Application
  - 8.5.6.1.4. Market size and forecast, by End User
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Market size and forecast, by Product Type
  - 8.5.6.2.2. Market size and forecast, by Material
  - 8.5.6.2.3. Market size and forecast, by Application
  - 8.5.6.2.4. Market size and forecast, by End User
  - 8.5.6.3. United Arab Emirates
  - 8.5.6.3.1. Market size and forecast, by Product Type
  - 8.5.6.3.2. Market size and forecast, by Material
  - 8.5.6.3.3. Market size and forecast, by Application
  - 8.5.6.3.4. Market size and forecast, by End User
  - 8.5.6.4. South Africa
  - 8.5.6.4.1. Market size and forecast, by Product Type
  - 8.5.6.4.2. Market size and forecast, by Material
  - 8.5.6.4.3. Market size and forecast, by Application
  - 8.5.6.4.4. Market size and forecast, by End User
  - 8.5.6.5. Rest of LAMEA
  - 8.5.6.5.1. Market size and forecast, by Product Type
  - 8.5.6.5.2. Market size and forecast, by Material
  - 8.5.6.5.3. Market size and forecast, by Application
  - 8.5.6.5.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Stryker
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. B. Braun Melsungen AG
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
10.3. Zimmer Biomet
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.3.7. Key strategic moves and developments
10.4. Smith+Nephew
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
10.5. Johnson & Johnson
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
10.6. Orthopaedic Implant Company
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
10.7. Orthofix Holdings, Inc.
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. Wright Medical Group N.V.
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
10.9. Advanced Orthopaedic Solutions
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments
10.10. Aysam Ortopedi & Tibbi Cihazlar
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments